[Which psychiatric comorbidities in cannabis dependence during adolescence? Comparison of outpatients and controls]. / Quelles comorbidités psychiatriques dans la dépendance au cannabis à l'adolescence ? Comparaison de patients consultants et de témoins.

BACKGROUND: The use of illicit substances, in particular cannabis, among French adolescents and young adults has become an important public health concern. A better understanding of the mechanisms involved in pathological substance use is nowadays critical. Psychiatric comorbidities have been previously reported in adult substance abusers but are less documented in adolescents, especially regarding cannabis dependence. OBJECTIVES: We investigated mental health problems in adolescents and young adults, seeking treatment for their problematic cannabis use, comparatively to healthy controls, taking into account the participant's gender and age. Moreover, we explored the relationships between psychiatric diagnosis and substance use modalities. METHODS: In total, 100 young patients (80 males - mean age 18.2 (SD=2.9; [14 to 25] years old)) with a cannabis dependence (DSM-IV-TR criteria) seeking treatment in an addiction unit, and 82 healthy control subjects (50 males - mean age 18.3 (SD=3.4; [14 to 25] years old)) with no substance misuse diagnostic other than for alcohol, participated in the study. The MINI was administered to evaluate cannabis dependence, and DSM-IV axis I comorbid diagnosis, and a semi-structured interview was used to determine psychoactive substance use. RESULTS: Statistical analyses revealed that 79 % of the patients reported at least one other non-drug or alcohol comorbid diagnosis, versus 30.5 % in the control group (χ2=16.83; P<0.001). Logistic regression indicated that participants with a psychiatric diagnosis had an 8.6 times higher risk (P<0.001; OR 95 % CI=[4.38-16.81]) of being patients. Significant inter-group differences and OR were noted for several diagnoses: dysthymia over the previous 2years (χ2=14.06; P<0.001; OR=10.63; OR 95 % CI=[2.41-46.87]), life-time panic attack disorder (χ2=4.15; P<0.042; OR=3.59; OR 95 % CI=[0.98-13.19]), alcohol abuse (χ2=47.72; P<0.001; OR=66.27; OR 95 % CI=[8.87-495.11]) and dependence (V=0.230; P=0.001) and generalized anxiety disorder (χ2=7.46; P=0.006-OR=3.57; OR 95 % CI=[1.37-9.30]). On the whole, the females (n=20) of our clinical sample presented significantly more comorbid diagnoses than the males (n=80) (95 % versus 75 %; χ2=6.25, P=0.011). These significant gender differences were found for life-time eating disorder (V=0.352; P=0.007) and generalized anxiety disorder diagnoses (V=0.278; P=0.013). Moreover, young adult patients (19-25years old; n=35) presented, on the whole, significantly more comorbid diagnoses than adolescent patients (14-18years old; n=65) (70.8 % versus 94.3 %; χ2=7.58, P=0.006). These age inter-group differences were found for several diagnoses: alcohol dependence (6.2 % versus 20 %; V=0.211, P=0.047), dysthymia over the past 2years (13.8 % versus 34.3 %; χ2=5.73, P=0.017) and generalized anxiety disorder (12.3 % versus 40 %; χ2=10.17, P=0.001). Various associations were observed between psychiatric comorbid diagnosis and substance use indicators. CONCLUSION: This study demonstrates that cannabis dependence in adolescents and young adults is related to great psychological distress and puts emphasis on the importance of substance use prevention as early as middle school. Moreover, the psychiatric features of adolescents and young adults need to be taken into consideration for treatment planning.

[Negative perceptions of the risks associated with gaming in young adolescents: An exploratory study to help thinking about a prevention program]. / Représentations des risques associés à l'usage des jeux vidéo chez les jeunes adolescents : une étude exploratoire pour aider à penser la prévention.

Given the growing use of video games and the growing number of adolescents with Internet gaming disorder (IGD), prevention in this area is necessary. The objective of this study was to investigate the use and most particularly the representations of the risks associated with the use of video games in young adolescents by comparing problematic (PGs) and nonproblematic gamers (NPGs). Gender differences were also explored. Five Parisian middle schools participated in this study and 434 adolescents (231 boys, mage=13.2 years; 203 girls, mage=13.1 years) answered several questions concerning videogames (including the Game Addiction Scale). Among all participants (n=434), 37 students (n=8.8%) could be considered PGs. Of these, 29 (n=78.4%) were boys. Generally, sample students' surf and play a great deal during the week: they spend an average of 2h per day playing video games and 4h per day on the Internet. The number of screens at home is significantly higher in PGs compared to NPGs, the remaining set at a high level (n>10). Most middle school students believe that time spent on video games can have an impact on physical and mental health but they have no impact on academic performance. The two types of video games responsible for problematic use were role-play games and first-person shooter games. Most negative consequences are reported more by girls than boys: eating problems (P=.037), sleep problems (P=.040), vision problems (P=.002), conflicts with parents (P<001), loss of time (P=.003), and lack of school investment (P<.001). For all participants, the main reasons for IGD were poor academic performance, lack of friends, lack of self-confidence and family problems. In NPGs, girls reported more than boys that family problems (P=.003), lack of self-confidence (P=.005) and negative self-image (P=.007) led to IGD. The three main features of the individual with IGD reported by PGs and NPGs is the failure to stop playing, playing instead of fulfilling one's obligations and doing nothing but play. Most of the respondents believed that one can be addicted to video games and that they can have an impact on physical and mental health. Adolescents are more aware of the impact gaming generates on themselves than on their relationship with the environment (school and family). These preliminary exploratory findings indicate that preventive action could be promoted for adolescents. To promote life skills, and given that girls often report more negative consequences than boys, it seems important to include these skills in prevention programs.

[Consumption of cannabis in adolescents]. / Abus et dépendance au cannabis à l'adolescence : diagnostic.

Over the past 10 years, the consumption of cannabis among adolescents has dramatically increased. Today, adolescent cannabis use is a major public health problem. Two forms of cannabis are commonly smoked: herb (marijuana) and resin. These forms have a high concentration of tetrahydrocannabinol, the active molecule of cannabis. Recent research has helped understand how the cannabinoid system works. This system combines specific receptors and specific molecules: the endocannabinoids. The effects of cannabis use are now well documented. Some adolescents report subjective positive effects. They use it not only on a recreational basis, but also to deal with their emotions. Over the long term, cannabis increases the risk of depression and schizophrenia for those adolescents who are at risk. Use, misuse, and dependence are frequently associated with heavy psychopathologic problems such as vulnerability and depression. Many cannabis dependence psychotherapies have shown their efficacy and efficiency. Motivational interviews, cognitive behavioral therapy, multidimensional family therapy (MDFT), and residential treatment have proved highly effective. MDFT seems very effective, especially in cases of heavy use.

[Comparison of European therapies for cannabis addiction among adolescents]. / Comparaison de thérapies européennes pour adolescents présentant une addiction au cannabis.

BACKGROUND: In European countries, cannabis abuse and dependence among adolescents has become a public health priority. Since 2002, studies have shown that persons seeking treatment for cannabis use are increasing. Over the past ten years, the involvement of many structures working on this topic has permitted an expansion and a diversification of treatment protocols. Moreover, international scientific studies, mainly conducted in the United States, have demonstrated the effectiveness of therapies based on motivation interviews, cognitive behavioral therapy (CBT) and family approach. Among these treatments, the multi-dimensional family therapy (MDFT), developed by the team of Professor Liddle in Miami, showed great efficiency in young adolescents with cannabis abuse problems. Five European countries therefore decided to build a randomized control study (RCT) comparing MDFT to the treatments that were commonly used. For the purpose of the research, the usual treatments had to be described and were named treatment as usual (TAU). Besides the obvious interest of implementing MDFT in Europe, it seems equally important to highlight the investment that has been made by all the European structures. The goal of this article is to describe and share the previous experience of all centers that have participated in the INCANT trial including the Netherlands, Germany, Belgium, Switzerland and France in the field of cannabis adolescent abusers. METHODOLOGY: To describe and compare European treatment as usual (TAU), we visited each structure to meet and to interview the teams regarding their practices. To perform these interviews, we used a semi directive questionnaire we had built previously. We completed the therapist's interviews with their written clinical protocol (when they had one) and a video/audiotaped session or written session. Data collection took place in five addiction centers: Therapy laden in Germany, Phoenix foundation in Switzerland, Cannabis clinic in Belgium, Palm Huis in Holland and Emergence and CEDAT in France. RESULTS: In terms of monitoring arrangements, there are many similarities between the European TAU. Indeed, all European centers were practicing individual therapy mainly focusing on the adolescent, and therapists were involving parents. In almost all European countries, the teenager was seen at one session per week, the parents were seen once a month and the duration of the therapy was about 6 months. The interview analysis has revealed that between countries, despite therapeutic techniques and differences in psychopathological approach, a global care process remained quite common. The therapeutic process, in all countries, was organized in two phases: build the therapeutic alliance and assess the situation with the adolescent, and help to coach him/her to enhance changes. DISCUSSION/CONCLUSION: The comparison of the TAU highlights the difficulties to see differences between models of psychotherapies. Are the psychotherapies really different or is it just a matter of the therapists, experience and good will? The debate is open and articles have shown arguments for both hypotheses. The analysis of our TAU indeed shows a common base, but as therapists started to formalize what they usually do, differences appear. The Incant study, in which TAU was compared to a formalized family therapy, clearly indicates differences between therapies, but only with heavy cases. Perhaps the more cases became complicated, the more there's a need for formalization and of course this will lead to differences between models.

[Multidimensional family therapy: which influences, which specificities?]. / La thérapie familiale multidimensionnelle (MDFT) : quelles influences, quelles spécificités ?

BACKGROUND: Among illegal psycho-active drugs, cannabis is the most consumed by French adolescents. Multidimensional family therapy (MDFT) is a family-based outpatient therapy which has been developed for adolescents with drug and behavioral problems. MDFT has shown its effectiveness in adolescents with substance abuse disorders (notably cannabis abuse) not only in the United States but also in Europe (International Cannabis Need of Treatment project). MDFT is a multidisciplinary approach and an evidence-based treatment, at the crossroads of developmental psychology, ecological theories and family therapy. Its psychotherapeutic techniques find its roots in a variety of approaches which include systemic family therapy and cognitive therapy. OBJECTIVE: The aims of this paper are: to describe all the backgrounds of MDFT by highlighting its characteristics; to explain how structural and strategy therapies have influenced this approach; to explore the links between MDFT, brief strategic family therapy and multi systemic family therapy; and to underline the specificities of this family therapy method. DISCUSSION: The multidimensional family therapy was created on the bases of 1) the integration of multiple therapeutic techniques stemming from various family therapy theories; and 2) studies which have shown family therapy efficiency. Several trials have shown a better efficiency of MDFT compared to group treatment, cognitive-behavioral therapy and home-based treatment. Studies have also highlighted that MDFT led to superior treatment outcomes, especially among young people with severe drug use and psychiatric co-morbidities. In the field of systemic family therapies, MDFT was influenced by: 1) the structural family therapy (S. Minuchin), 2) the strategic family theory (J. Haley), and 3) the intergenerational family therapy (Bowen and Boszormenyi-Nagy). MDFT has specific aspects: MDFT therapists think in a multidimensional perspective (because an adolescent's drug abuse is a multidimensional disorder), they work with the system and the subsystem, focusing on the emotional expression and the parental and adolescent enactment (a principle of change and intervention). MDFT includes four modules (adolescent, parent, family interaction, and extra-familial systems) in three steps (1) build the foundation, (2) prompt action and change by working the themes, and (3) seal the changes and exit). The supervision philosophy and methodology is also based on the principle of multidimensionality. Indeed, many different supervision methods are used in a coordinated way to produce the required adherence and clinical skill (written case conceptualizations, videotape presentation and live supervision). CONCLUSION: Family vulnerability and chronicity factors are a major challenge of modern research. MDFT questions the reciprocal adjustments that have to be made by the subject and his/her familial environment. It also helps to clarify the therapeutic interventions in order to enhance better adolescent development. For this purpose, MDFT offers a specific therapeutic frame, for it is a family therapy focused on adolescents with cannabis abuse problems. Its action and questioning on parental practices and adolescents lead to better psycho-educational support. It focuses the therapeutic process on emotions and family capacity for change.

[Vascular calcifications and vitamin K deficiency: a modifiable risk factor in chronic kidney disease]. / Calcifications vasculaires et déficit en vitamine K: un facteur de risque modifiable dans l'insuffisance rénale chronique.

The mechanisms of vascular calcifications in chronic renal failure are complex. Apart for clotting factors, vitamin K-dependent proteins include matrix Gla protein. Glutamic acid residues in matrix Gla protein are carboxylated by vitamin K-dependent gamma-carboxylase, which enables it to inhibit calcification. The purpose of this review is to discuss available evidence implicating vitamin K as a modifiable risk factor in the pathogenesis of vascular calcification in renal diseases.

[Cocaine induced psychotic disorders: a review]. / Les troubles psychotiques induits par la cocaïne: une revue synthétique.

Cocaine remains the second most used illicit drug in Europe, after cannabis, though levels of use vary between countries. This psychostimulant has become a noticeable part of the European drug scene. Cocaine dependence, a chronic, relapsing and multifactorial disorder, is a significant worldwide public health problem with somatic, legal, social, cognitive and psychological complications. The relationship between clinical psychotic symptoms and use of specific substances other than cannabis has received minimal attention in the literature. Psychotic symptoms and experience of paranoia and suspiciousness are reported during the use and the withdrawal of cocaine. Furthermore, although psychotic symptoms were found to be common among substance users, the risk for development of chronic psychotic disorder was found. In the light of recent epidemiological data stating that there is an increased cocaine use, that there is an increased number of patients entering drug treatment for primary cocaine use in Europe for several years and that cocaine users are an heterogeneous group, we made a review on the specific topic of cocaine-induced psychotic disorders. This review is based on Medline, EMBASE, PsycINFO and Google Scholar searches of English and French-language articles published between 1969 and February, 2010.

[Chronic renal failure: what diet?]. / Insuffisance rénale chronique: quel régime?

A low protein diet has been traditionally advocated in patients with chronic renal failure (CRF), in order to slow its progression. However, CRF is often associated with malnutrition, aggravating its prognosis, especially in elderly patients. In severe CRF, the spontaneous reduction of appetite coupled with additional restrictions regarding sodium, potassium and phophates may further impact on nutrition status. The potential benefit of a low protein diet is therefore questionable. We only recommend a moderately restricted protein diet (0,8 g/kg/day) in selected patients with no sign of malnutrition. This strategy, if applied, must be supported by a multidisciplinary approach involving a nephrologist and a specialised dietician. Additional dietary restrictions are not justified, except in particular situations.

[Causality and psychopathological course in a cannabis dependency case]. / Causalité et évolution psychopathologiques dans une dépendance au cannabis.

We analyzed the behavior of teenagers who use cannabis in order to identify the drive leading to cannabis abuse and the perceived benefit which apparently sustains dependency. This analysis pointed out the following issues: identification, alterity modulation, modification of thinking activity, pursual of a psychopathological state of deterioration. This short clinical dissertation should be completed by further more deeply oriented clinical research.

Effect of daytime oral melatonin administration on neurobehavioral performance in humans.

The pineal hormone melatonin has been proposed as a potential treatment for insomnia and circadian rhythm disorders, as experienced by shiftworkers and transmeridian travellers. If melatonin is to be used in a clinical setting, it is important that the neurobehavioral performance effects associated with its administration be identified. As with other drugs that increase sleepiness, e.g., sedatives and antihistamines, inappropriate effects on neurobehavioral performance could result in a corresponding increase in side effects and potential risk to users. The aim of this study was to investigate the effects of 5 mg oral melatonin, administered at 12.30 hr to 16 young (22.4 +/- 1.8 years), healthy subjects (ten males and six females), on the following neurobehavioral performance tasks: two-choice visual reaction and response time, unpredictable tracking, extended two-choice visual reaction and response time, and simple auditory response and reaction time, in a randomised, double-blind crossover protocol. Following melatonin administration, significant decrements in performance on the tracking task and on response and reaction time scores for the visual choice and extended two-choice visual tasks were observed. The profile of these performance decrements across the experimental sessions were found to closely map the profile of salivary melatonin levels. The findings of the present study highlight the significant neurobehavioral performance effects associated with the daytime administration of melatonin.